In CKD–mineral and bone disorder, dysregulated FGF23, klotho, vitamin D, and PTH cause progressive hyperphosphatemia, hypercalcemia, and hyperparathyroidism and contribute to the increased cardiovascular risk in patients with renal failure [144]. Here, FGF23 is linked to chronic kidney disease.